Assessment of nerve stimulation-induced release of purines from mouse kidneys by tandem mass spectrometry

Journal of Pharmacology and Experimental Therapeutics

Volumn 325, Issue 3, 2008, Pages 920-926

  Ren, Jin ^a   Mi, Zaichuan ^a   Jackson, Edwin K ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE; ADENOSINE PHOSPHATE; CYCLIC AMP; GUANOSINE; INOSINE; PURINE;

ADRENERGIC TRANSMISSION; ANALYSIS OF VARIANCE; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; KIDNEY; KIDNEY INNERVATION; KIDNEY PERFUSION; KIDNEY VEIN; LIQUID CHROMATOGRAPHY; MALE; MOUSE; NERVE STIMULATION; NONHUMAN; PRIORITY JOURNAL; SYMPATHETIC NERVE; TANDEM MASS SPECTROMETRY;

ANIMALS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; KIDNEY; MALE; MICE; MICE, INBRED C57BL; PURINES; SYMPATHETIC NERVOUS SYSTEM; TANDEM MASS SPECTROMETRY;

EID: 44249090250     PISSN: 00223565     EISSN: 15210103     Source Type: Journal    
DOI: 10.1124/jpet.108.137752     Document Type: Article

References (29)

1. Burnstock G (1995) Noradrenaline and ATP: cotransmitters and neuromodulators. J Physiol Pharmacol 46:365-384.
2. DiBona GF (2004) The sympathetic nervous system and hypertension: recent developments. Hypertension 43:147-150.
3. DiBona GF and Kopp UC (1997) Neural control of renal function. Physiol Rev 77:75-197.
4. Dubey RK, Gillespie DG, Mi Z, and Jackson EK (2005) Adenosine inhibits PDGF-induced growth of human glomerular mesangial cells via A2B receptors. Hypertension 46:628-634.
5. Ekas RD Jr, Steenberg ML, Eikenburg DC, and Lokhandwala MF (1981) Presynaptic inhibition of sympathetic neurotransmission by adenosine in the rat kidney. Eur J Pharmacol 76:301-307.
6. 3H]-adenine labelled rabbit kidney following sympathetic nerve stimulation, and its inhibition by alpha-adrenoceptor blockage. Br J Pharmacol 64:239-245.
7. Hedqvist P and Fredholm BB (1976) Effects of adenosine on adrenergic neurotransmission: prejunctional inhibition and postjunctional enhancement. Naunyn Schmiedebergs Arch Pharmacol 293:217-223.
8. Hedqvist P, Fredholm BB, and Olundh S (1978) Antagonistic effects of theophylline and adenosine on adrenergic neuroeffector transmission in the rabbit kidney. Circ Res 43:592-598.
9. Jackson EK and Dubey RK (2001) Role of the extracellular cAMP-adenosine pathway in renal physiology. Am J Physiol Renal Physiol 281:F597-F612.
10. Jackson EK and Mi Z (2000) Preglomerular microcirculation expresses the cAMP-adenosine pathway. J Pharmacol Exper Ther 295:23-28.
11. Jackson EK and Mi Z (2008) Regulation of renal ecto-phosphodiesterase by protein kinase C and sodium diet. J Pharmacol Exper Ther 325:210-216.
12. Jackson EK, Mi Z, Koehler MT, Carcillo JA Jr, and Herzer WA (1996) Injured erythrocytes release adenosine deaminase into the circulation. J Pharmacol Exper Ther 279:1250-1260.
13. Jackson EK and Ohnishi A (1987) Development and application of a simple microassay for adenosine in rat plasma. Hypertension 10:189-197.
14. Jackson EK and Raghvendra DK (2004) The extracellular cyclic AMP-adenosine pathway in renal physiology. Annu Rev Physiol 66:571-599.
15. Jackson EK, Zacharia LC, Zhang M, Gillespie DG, Zhu C, and Dubey RK (2006) cAMP-adenosine pathway in the proximal tubule. J Pharmacol Exper Ther 317:1219-1229.
16. Jamal Z, Afkham-Ebrahimi A, and Saggerson ED (1988) A novel assay for 5′-nucleotidase using 1,N6-etheno-AMP as substrate, and comments on the properties of the reaction product, ethenoadenosine. Biochem J 250:369-373.
17. Katholi RE, McCann WP, and Woods WT (1985) Intrarenal adenosine produces hypertension via renal nerves in the one-kidney, one clip rat. Hypertension 7:I88-93.
18. Katholi RE, Whitlow PL, Hageman GR, and Woods WT (1984) Intrarenal adenosine produces hypertension by activating the sympathetic nervous system via the renal nerves in the dog. J Hypertens 2:349-359.
19. 1-Adrenoceptor activation increases ecto-5′-nucleotidase activity and adenosine release in rat cardiomyocytes by activating protein kinase C. Circulation 91:2226-2234.
20. Mi Z and Jackson EK (1995) Metabolism of exogenous cyclic AMP to adenosine in the rat kidney. J Pharmacol Exper Ther 273:728-733.
21. Mi Z and Jackson EK (1999) Effects of α- and β-adrenoceptor blockade on purine secretion induced by sympathetic nerve stimulation in the rat kidney. J Pharmacol Exper Ther 288:295-301.
22. 1 receptor antagonists and the kidney. Curr Opin Nephrol Hypertens 12:497-502.
23. Vallon V, Muhlbauer B, and Osswald H (2006) Adenosine and kidney function. Physiol Rev 86:901-940.
24. Watson AMD, Hood SG, and May CN (2006) Mechanisms of sympathetic activation in heart failure. Clin Exp Pharmacol Physiol 33:1269-1274.
25. Westfall DP, Todorov LD, and Mihaylova-Todorova ST (2002) ATP as a cotransmitter in sympathetic nerves and its inactivation by releasable enzymes. J Pharmacol Exper Ther 303:439-444.
26. Winternitz SR, Katholi RE, and Oparil S (1980) Role of the renal sympathetic nerves in the development and maintenance of hypertension in the spontaneously hypertensive rat. J Clin Invest 66:971-978.
27. Winternitz SR and Oparil S (1982) Importance of the renal nerves in the pathogenesis of experimental hypertension. Hypertension 4:III108-III114.
28. Yaar R, Jones MR, Chen JF, and Ravid K (2005) Animal models for the study of adenosine receptor function. J Cell Physiol 202:9-20.
29. Zucker IH (2006) Novel mechanisms of sympathetic regulation in chronic heart failure. Hypertension 48:1005-1011.